dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
locoid 0,1% kutanopløsning
nordic prime aps - hydrocortisonbutyrat - kutanopløsning - 0,1%
tostran 20 mg/g gel
2care4 aps - testosteron - gel - 20 mg/g
dermovat 0,5 mg/ml kutanopløsning
2care4 aps - clobetasolpropionat - kutanopløsning - 0,5 mg/ml
gallup hi-aktiv 490 vandopløseligt koncentrat
barclay chemicals manufacturing ltd. - glyphosat - vandopløseligt koncentrat - 490 g/l glyphosat
gallup hi-aktiv vandopløseligt koncentrat
barclay chemicals manufacturing ltd. - glyphosat - vandopløseligt koncentrat - 490 g/l glyphosat
glyfonova 360 sl vandopløseligt koncentrat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - glyphosat - vandopløseligt koncentrat - 360 g/l glyphosat
glyfonova plus flydende middel
fmc agricultural solutions a/s (tidligere: cheminova a/s) - glyphosat - flydende middel - 360 g/l glyphosat
glyfonova accelerator vandopløseligt koncentrat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - glyphosat - vandopløseligt koncentrat - 450 g/l glyphosat
glyfonova klar til brug vandopløseligt koncentrat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - glyphosat - vandopløseligt koncentrat - 7,2 g/l glyphosat